The KinematX Midcarpal Total Wrist Arthroplasty Registry

NCT ID: NCT05719935

Last Updated: 2023-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-26

Study Completion Date

2035-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist replacement study.

The main questions it aims to answer are:

* What is the range of motion (flexion, extension, radial, ulnar, grip and pinch strength) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.
* What are the patient reported outcomes (PROMIS, PRWE, HSS wrist expectations) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.
* How do range of motion and patient reported outcomes change over the 10 years after total wrist replacement surgery?

Participants will be followed according to standard of care and preoperative and post-operative information for up to 10 years after surgery will be collected and entered into an electronic data base. Patients are eligible to enroll into the registry before or after they have had their wrist replacement surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scapholunate Advanced Collapse (SLAC) Scapholunate Crystalline Advanced Collapse (SCAC) Scaphoid, Trapezium, and Trapezoid Advanced Collapse (STTAC) Carpal Tunnel Syndrome (CTS) Kienbock's Disease of Adults Radial Malunion Ulnar Translocation Post Traumatic Arthritis Inflammatory Arthritis Osteoarthritis Scaphoid Non-union Advanced Collapse (SNAC)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

KinematX patients

Patients undergoing total wrist replacement with the KinematX implant.

KinematX total wrist arthroplasty system

Intervention Type DEVICE

The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

KinematX total wrist arthroplasty system

The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* one of the following diagnoses and planned (or previously completed) total wrist arthroplasty with the KinematX total wrist:

* osteoarthritis or post-traumatic arthritis
* scapholunate advanced collapse (SLAC/SNAC wrist),
* inflammatory arthritis (rheumatoid, psoriatic, other),
* crystalline advanced collapse (SCAC),
* STT advanced collapse (STTAC),
* ulnar translocation,
* KienbÓ§ck disease,
* radial malunion

Exclusion Criteria

* \<18 years of age
* \>85 years of age
* Prisoners
* Children
* Pregnant women
* Contraindications to receiving the KinematX:

* Local, distant or systematic acute or chronic soft tissue or bony infection
* Physiologically or psychologically compromised patient
* Active wrist synovitis or severe carpal bone erosion
* Suspected or documented metal allergy or intolerance
* Insufficient extensor tendons
* Inadequate skin, bone, neural or vascular status
* Severe carpal bone malalignment, displacement, absorption, neoplastic, or carpal bone pathology
* Sepsis
* Osteomyelitis
* Uncontrolled/untreated osteoporosis or metabolic bone disease
* Metabolic or endocrinologic bone disorders
* Osteomalacia
* Distant foci of infections which may spread to the implant site
* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Extremity Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian Smekal

Role: STUDY_DIRECTOR

Extremity Medical

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University

Loma Linda, California, United States

Site Status RECRUITING

Florida Orthopaedic Institute

Tampa, Florida, United States

Site Status RECRUITING

Franciscan Health

Indianapolis, Indiana, United States

Site Status RECRUITING

Hospital for Special Surgery

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Brian Smekal

Role: CONTACT

+1 952-836-5698

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elisabeth Clarke

Role: primary

Debbi Warren

Role: primary

Craig Dent

Role: backup

Stephanie Alford

Role: primary

Benjamin Basseri

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

112020-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.